North America: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Missouri Moves For Fairness And Transparency For Pharmacy Benefit Managers

n a bold move to protect patients, independent pharmacies and healthcare plan sponsors, Missouri lawmakers have introduced landmark legislation aimed at reforming the practices of pharmacy benefit managers (PBMs).

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Taking The LEAD: CMS Unveils The New LEAD Model, Focused On Long-Term Primary Care Success

On December 18, 2025, the Centers for Medicare & Medicaid Services (CMS) Innovation Center announced the Long-term Enhanced ACO Design (LEAD) Model...

United States Healthcare

BB

Bass, Berry & Sims

Reversal Of An Obviousness-Inherency Position

An obviousness rejection was recently reversed by the Patent Trial and Appeal Board (PTAB) by the panel of Administrative Patent Judges...

United States Healthcare

OM

Oblon, McClelland, Maier & Neustadt, L.L.P

Beyond Borders 2025: The Top Five Considerations On The Road To Success In Cross-border Life Sciences M&A

Traditional M&A remains important, but companies are increasingly favouring licensing, joint ventures and co-development deals to manage risk and retain flexibility...

United States Healthcare

KM

Katten Muchin Rosenman LLP

VC Investment In Canada For Life Sciences Companies

Canada Healthcare

MT

McCarthy Tétrault LLP

FDA Approves New Dose For Celltrion's OMLYCLO (Omalizumab-Igec)

United States Healthcare

GP

Goodwin Procter LLP

OptumRx Follows Other PBMs' Playbooks: Therapeutic Class Caps Signal The Next Phase Of PBM Oversight

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

IRS Touches Up The One Big Beautiful Bill

United States Healthcare

BS

Ballard Spahr LLP

From Complexity To Clarity: How The EU Commission Plans To Overhaul The MDR And IVDR

United States Healthcare

AP

Arnold & Porter

5 Key Questions On The Family Certified Nursing Assistant (CNA) Model

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

Taking Action On Food Insecurity

Canada Healthcare

ML

McMillan LLP

EC Releases Proposed Biotech Act

Worldwide Healthcare

BC

Bergeson & Campbell

HHS OIG Clarifies Scope Of Discount Safe Harbor In Advisory Opinion

United States Healthcare

AP

Arnold & Porter

Medicare Provider And Supplier Enrollment Policy Updates

United States Healthcare

BB

Bass, Berry & Sims

Top 5 Takeaways From "Advanced Mediation Strategies For Handling The Toughest Situations"

United States Litigation

J

JAMS

What Honeybees Have Taught Me About Dispute Resolution

United States Litigation

J

JAMS

Early Mediation: Is Your Case A Likely Candidate?

United States Litigation

J

JAMS

Back To School 2025: Title IX Updates And How ADR Can Help Universities Resolve Disputes (Podcast)

United States Litigation

J

JAMS

Hot Topics In International Trade A Tariff Christmas Message For US Kids (Video)

United States International

BG

Braumiller Law Group, PLLC

See more

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Food and Drugs Law

What You Should Know About The Freestyle Libre 3 Recall

There is little doubt that medical technology has dramatically enhanced the quality and longevity of our lives. We continue to see innovations that not only aid in earlier detection of disease...

Worldwide Litigation

GP

Gluckstein Lawyers

New York Announces Additional Steps To Address PFAS

On December 11, 2025, the New York State Department of Environmental Conservation (DEC) announced several new initiatives regarding per- and polyfluoroalkyl substances (PFAS).

United States Environment

BC

Bryan Cave Leighton Paisner

POTUS Orders DOJ To Complete Rulemaking Process To Reschedule Marijuana Expeditiously: Three Employer Considerations

The EO directs the DOJ to complete the rulemaking process to reschedule marijuana to a Schedule III drug.

United States Cannabis

JL

Jackson Lewis P.C.

Beyond Borders 2025: The Top Five Considerations On The Road To Success In Cross-border Life Sciences M&A

United States Healthcare

KM

Katten Muchin Rosenman LLP

PFAS In Food Packaging: State-by-state Regulations

United States Environment

BC

Bryan Cave Leighton Paisner

VC Investment In Canada For Life Sciences Companies

Canada Healthcare

MT

McCarthy Tétrault LLP

POTUS Orders DOJ To Complete Rulemaking Process To Reschedule Marijuana Expeditiously

United States Cannabis

JL

Jackson Lewis P.C.

Extended Holiday Hours For Liquor Licence Holders

Cayman Islands Media & IT

CI

Cayman Islands Government

FDA Approves New Dose For Celltrion's OMLYCLO (Omalizumab-Igec)

United States Healthcare

GP

Goodwin Procter LLP

See more

Healthcare

Missouri Moves For Fairness And Transparency For Pharmacy Benefit Managers

n a bold move to protect patients, independent pharmacies and healthcare plan sponsors, Missouri lawmakers have introduced landmark legislation aimed at reforming the practices of pharmacy benefit managers (PBMs).

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

What You Should Know About The Freestyle Libre 3 Recall

There is little doubt that medical technology has dramatically enhanced the quality and longevity of our lives. We continue to see innovations that not only aid in earlier detection of disease...

Worldwide Litigation

GP

Gluckstein Lawyers

Taking The LEAD: CMS Unveils The New LEAD Model, Focused On Long-Term Primary Care Success

On December 18, 2025, the Centers for Medicare & Medicaid Services (CMS) Innovation Center announced the Long-term Enhanced ACO Design (LEAD) Model...

United States Healthcare

BB

Bass, Berry & Sims

Beyond Borders 2025: The Top Five Considerations On The Road To Success In Cross-border Life Sciences M&A

United States Healthcare

KM

Katten Muchin Rosenman LLP

VC Investment In Canada For Life Sciences Companies

Canada Healthcare

MT

McCarthy Tétrault LLP

IRS Touches Up The One Big Beautiful Bill

United States Healthcare

BS

Ballard Spahr LLP

From Complexity To Clarity: How The EU Commission Plans To Overhaul The MDR And IVDR

United States Healthcare

AP

Arnold & Porter

5 Key Questions On The Family Certified Nursing Assistant (CNA) Model

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

State AG News: Unfair Fees, Medicaid Fraud, Data Privacy (December 11-17, 2025)

United States Consumer

CM

Crowell & Moring LLP

See more

Life Sciences, Biotechnology & Nanotechnology

What You Should Know About The Freestyle Libre 3 Recall

There is little doubt that medical technology has dramatically enhanced the quality and longevity of our lives. We continue to see innovations that not only aid in earlier detection of disease...

Worldwide Litigation

GP

Gluckstein Lawyers

Reversal Of An Obviousness-Inherency Position

An obviousness rejection was recently reversed by the Patent Trial and Appeal Board (PTAB) by the panel of Administrative Patent Judges...

United States Healthcare

OM

Oblon, McClelland, Maier & Neustadt, L.L.P

POTUS Orders DOJ To Complete Rulemaking Process To Reschedule Marijuana Expeditiously: Three Employer Considerations

The EO directs the DOJ to complete the rulemaking process to reschedule marijuana to a Schedule III drug.

United States Cannabis

JL

Jackson Lewis P.C.

Beyond Borders 2025: The Top Five Considerations On The Road To Success In Cross-border Life Sciences M&A

United States Healthcare

KM

Katten Muchin Rosenman LLP

VC Investment In Canada For Life Sciences Companies

Canada Healthcare

MT

McCarthy Tétrault LLP

POTUS Orders DOJ To Complete Rulemaking Process To Reschedule Marijuana Expeditiously

United States Cannabis

JL

Jackson Lewis P.C.

A Closer Look At The Life Sciences Industry: 2025 Life Sciences Report

United States Commercial

AM

Alvarez & Marsal

EC Releases Proposed Biotech Act

Worldwide Healthcare

BC

Bergeson & Campbell

Updated NHS IP Guidance: Unlocking Healthcare Innovation

United States Healthcare

AP

Arnold & Porter

See more

Latest Videos

See more

Critical Medical Device Series: Part X Balancing Risk And Innovation: Fraud And Abuse Trends For MedTech (Video)

AP

Arnold & Porter

Strategic Synergy At Atlantic Health: Saad Ehtisham On How Leadership Alignment Fuels Transformation (Video)

AM

Alvarez & Marsal

Album 9: Track 12 Steady On – Trilliant Health (Part 2) (Podcast)

PL

Polsinelli LLP

Navigating Health Plan M&A: Strategies For Success In The Medicare Advantage Market (Podcast)

RG

Ropes & Gray LLP

The Journey To Better Healthcare With Ben Kruger (Video)

OK

Offit Kurman

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More